A Study of Supaglutide in Chinese Type 2 Diabetes Patients
Status:
Completed
Trial end date:
2021-03-16
Target enrollment:
Participant gender:
Summary
A study on the safety, efficacy, pharmacokinetics and pharmacodynamics of Supaglutide dosing
weekly and bi-weekly in patients with type 2 diabetes mellitus.